Clinical and angiographic outcomes of Mycophenolate versus Methotrexate in South Asian patients of Takayasu arteritis: Results from an open-label, randomised controlled trial.

Shivraj PadiyarDebashish DandaRuchika GoelElizabeth JosephAswin M NairGeorge JosephBelavendra Antonisamy

Published in: Modern rheumatology (2022)

The results showed numerically better outcomes towards MMF, with a longer time to first failure than Methotrexate(9 months versus 4.5 months, p=0.052). No significant difference was seen in the angiographic outcomes.

Keyphrases

end stage renal disease
high dose
chronic kidney disease
newly diagnosed
ejection fraction
study protocol
prognostic factors
type diabetes
clinical trial
peritoneal dialysis
adipose tissue